Clinical investigations in diabetes patients had shown that increased expression of MIAT was markedly associated with diabetic retinopathy process, and the increased MIAT decreased the viability of ARPE-19 cells in vitro via targeting the TGF-β1 pathway [92]. The gene discussed is MIAT; the disease is diabetic retinopathy.